Literature DB >> 26584231

OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins.

Edward Harder1, Wolfgang Damm1, Jon Maple1, Chuanjie Wu1, Mark Reboul1, Jin Yu Xiang1, Lingle Wang1, Dmitry Lupyan1, Markus K Dahlgren1, Jennifer L Knight1, Joseph W Kaus1, David S Cerutti1, Goran Krilov1, William L Jorgensen2, Robert Abel1, Richard A Friesner3.   

Abstract

The parametrization and validation of the OPLS3 force field for small molecules and proteins are reported. Enhancements with respect to the previous version (OPLS2.1) include the addition of off-atom charge sites to represent halogen bonding and aryl nitrogen lone pairs as well as a complete refit of peptide dihedral parameters to better model the native structure of proteins. To adequately cover medicinal chemical space, OPLS3 employs over an order of magnitude more reference data and associated parameter types relative to other commonly used small molecule force fields (e.g., MMFF and OPLS_2005). As a consequence, OPLS3 achieves a high level of accuracy across performance benchmarks that assess small molecule conformational propensities and solvation. The newly fitted peptide dihedrals lead to significant improvements in the representation of secondary structure elements in simulated peptides and native structure stability over a number of proteins. Together, the improvements made to both the small molecule and protein force field lead to a high level of accuracy in predicting protein-ligand binding measured over a wide range of targets and ligands (less than 1 kcal/mol RMS error) representing a 30% improvement over earlier variants of the OPLS force field.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26584231     DOI: 10.1021/acs.jctc.5b00864

Source DB:  PubMed          Journal:  J Chem Theory Comput        ISSN: 1549-9618            Impact factor:   6.006


  547 in total

1.  Identification of a G-Protein-Independent Activator of GIRK Channels.

Authors:  Yulin Zhao; Peter Man-Un Ung; Gergely Zahoránszky-Kőhalmi; Alexey V Zakharov; Natalia J Martinez; Anton Simeonov; Ian W Glaaser; Ganesha Rai; Avner Schlessinger; Juan J Marugan; Paul A Slesinger
Journal:  Cell Rep       Date:  2020-06-16       Impact factor: 9.423

2.  Mechanism of Hormone Peptide Activation of a GPCR: Angiotensin II Activated State of AT1R Initiated by van der Waals Attraction.

Authors:  Khuraijam Dhanachandra Singh; Hamiyet Unal; Russell Desnoyer; Sadashiva S Karnik
Journal:  J Chem Inf Model       Date:  2019-01-16       Impact factor: 4.956

3.  Design and in Vivo Characterization of A1 Adenosine Receptor Agonists in the Native Ribose and Conformationally Constrained (N)-Methanocarba Series.

Authors:  Dilip K Tosh; Harsha Rao; Amelia Bitant; Veronica Salmaso; Philip Mannes; David I Lieberman; Kelli L Vaughan; Julie A Mattison; Amy C Rothwell; John A Auchampach; Antonella Ciancetta; Naili Liu; Zhenzhong Cui; Zhan-Guo Gao; Marc L Reitman; Oksana Gavrilova; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2019-01-03       Impact factor: 7.446

4.  6-Deoxy- and 11-Hydroxytolypodiols: Meroterpenoids from the Cyanobacterium HT-58-2.

Authors:  Joshua R Gurr; Timothy J O'Donnell; Yuheng Luo; Wesley Y Yoshida; Mary L Hall; Alejandro M S Mayer; Rui Sun; Philip G Williams
Journal:  J Nat Prod       Date:  2020-04-13       Impact factor: 4.050

5.  Escaping Atom Types in Force Fields Using Direct Chemical Perception.

Authors:  David L Mobley; Caitlin C Bannan; Andrea Rizzi; Christopher I Bayly; John D Chodera; Victoria T Lim; Nathan M Lim; Kyle A Beauchamp; David R Slochower; Michael R Shirts; Michael K Gilson; Peter K Eastman
Journal:  J Chem Theory Comput       Date:  2018-10-30       Impact factor: 6.006

6.  Molecular Mechanism of Resistance in a Clinically Significant Double-Mutant Variant of HCV NS3/4A Protease.

Authors:  Ashley N Matthew; Florian Leidner; Alicia Newton; Christos J Petropoulos; Wei Huang; Akbar Ali; Nese KurtYilmaz; Celia A Schiffer
Journal:  Structure       Date:  2018-08-23       Impact factor: 5.006

7.  qFit-ligand Reveals Widespread Conformational Heterogeneity of Drug-Like Molecules in X-Ray Electron Density Maps.

Authors:  Gydo C P van Zundert; Brandi M Hudson; Saulo H P de Oliveira; Daniel A Keedy; Rasmus Fonseca; Amelie Heliou; Pooja Suresh; Kenneth Borrelli; Tyler Day; James S Fraser; Henry van den Bedem
Journal:  J Med Chem       Date:  2018-12-06       Impact factor: 7.446

8.  High Yield Expression of Recombinant CD151 in E. coli and a Structural Insight into Cholesterol Binding Domain.

Authors:  Gayathri Purushothaman; Vijay Thiruvenkatam
Journal:  Mol Biotechnol       Date:  2019-12       Impact factor: 2.695

9.  Structural Analysis of the Active Site and DNA Binding of Human Cytidine Deaminase APOBEC3B.

Authors:  Shurong Hou; Tania V Silvas; Florian Leidner; Ellen A Nalivaika; Hiroshi Matsuo; Nese Kurt Yilmaz; Celia A Schiffer
Journal:  J Chem Theory Comput       Date:  2018-12-11       Impact factor: 6.006

10.  Relative binding affinity prediction of farnesoid X receptor in the D3R Grand Challenge 2 using FEP.

Authors:  Christina Schindler; Friedrich Rippmann; Daniel Kuhn
Journal:  J Comput Aided Mol Des       Date:  2017-09-12       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.